Member Info for Aether

Jonnyboy33

I read it but I started to worry and asked the supplemental question:

"Perhaps medics will simply start using viral based vaccines rather than using Pfizer vaccines and then using SNG in vulnerable patients?"

I need a beer!

Also, have a good weekend :-)

Brand - If you could answer the question, I would be most grateful. Thank you :)

Also, the viral vaccine is owned by Janssen.

Brand - good catch!

How does this benefit SNG exactly?

Perhaps medics will simply start using viral based vaccines rather than using Pfizer vaccines and then using SNG in vulnerable patients?

Same words and phrases.

Green bin.

Org.

Good find, wpa5!

Is the current laboratory technician leaving or is an additional one required?

Doc.Dan - Hope your feet are up and you're recovering with a hot toddy.

Check the posting history.

Check for familiar words and phrases.

Very familiar words and phrases.

Green Bin.

I have sent a polite email to Synairgen asking for clarification on this point.

They know they have to get the P2 trials right and the bio-markers and tests look like they will be critical.

I wouldn't be surprised if they postponed the P2 further until they can be sure of passing them with the right bio-markers and tests to identify the most suitable patients.

They want to pass the P2 tests and this is the last roll of the dice.

I suspect the P2 trials will be delayed and they will run the observational trial first.

They know they have to get the P2 trials right and the bio-markers and tests look like they will be critical.

Doc.Dan - Do you have doubts now? Looking at the RM interview he looks burned but well fed. I suspect they know this is their last roll of the dice. So, are desperate for it to work. If this fails, TFG will probably put someone on the board and have a a fire sale.

Org.

The worthless idiot is a ...

... Green rectangle.

I just watched the interview and RM was spot on. Targeting the right patients is critical for success now.

He was candid about what would happen if they just repeated a Clinical Trial without targeting.

I suspect they are waiting for more tests to be developed, bio-markers to be identified and the results of the observational studies to be analysed.

They know this is their last chance and they want to succeed for personal as well as professional reasons.

Why is there a call for an observational study after / or in addition to UNIVERSAL?

Why are there fewer P2 trials?

I am tempted to sell and buy back in at a reduced price in January.

Org.

The writing style makes it obvious now.

Comedy gold.

XD

The writing style makes it obvious now.

XD